Anthropic’s $50,000 Claude-credit grant gets called out as useless for rare-disease research

96Stats · x · 2026-07-22

Anthropic’s $50,000 Claude-credit grants draw criticism from a rare-disease researcher

A researcher who works on rare cancers and AI-assisted detection for uncommon spinal diseases argues that Anthropic’s new up to $50,000 in Claude usage credits is not the same as real research funding.

Key points from the reply:

For rare diseases, data scarcity is the main bottleneck, not model access.
Claude is described as useful in general, but weak on rare-data analysis because such cases are underrepresented in training data.
The commenter says they already work with hospitals in China that build specialized LLMs for rare diseases, which may be a better fit.
They also criticize the U.S. government for proposed NIH budget cuts of roughly 40%, arguing that labs doing biology need real funding, not credits.

The post is essentially a reaction to Anthropic’s AI for Science initiative and its first focused call for rare-disease research.

Original post →

Anthropic’s $50,000 Claude-credit grant gets called out as useless for rare-disease research

More from Companies & People